share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A：股东委托书决议
美股SEC公告 ·  2024/10/29 05:19

Moomoo AI 已提取核心信息

Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially...Show More
Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially avoiding delisting from the Nasdaq and attracting more investors and analysts. The meeting will also allow for the transaction of other matters that may properly come before the meeting. Only stockholders of record as of October 25, 2024, are entitled to notice of and to vote at the meeting. The company has emphasized the importance of stockholder votes and has provided instructions for voting by internet or by mail.
Conduit Pharmaceuticals Inc.宣布将于2024年12月18日举行虚拟股东年会。 会议将讨论几项关键议案，包括选举六名董事，批准Marcum LLP为截至2024年12月31日财政年度的独立注册公共会计师事务所，并通过关于公司普通股倒数拆股的修正案。 倒数拆股提议旨在以不少于1比10和不多于1比100的比率将已发行股份合并为较少数量，具体比率由董事会确定。 此举旨在提高公司股票的每股价格，可能避免从纳斯达克摘牌，并吸引更多投资者和分析师。 会议还将允许处理可能提请会议的其他事项。 只有截至2024年10月25日股东名册上的股东有权收到会议通知并参加会议。 公司强调了股东投票的重要性，并提供了通过互联网或邮寄进行投票的说明。
Conduit Pharmaceuticals Inc.宣布将于2024年12月18日举行虚拟股东年会。 会议将讨论几项关键议案，包括选举六名董事，批准Marcum LLP为截至2024年12月31日财政年度的独立注册公共会计师事务所，并通过关于公司普通股倒数拆股的修正案。 倒数拆股提议旨在以不少于1比10和不多于1比100的比率将已发行股份合并为较少数量，具体比率由董事会确定。 此举旨在提高公司股票的每股价格，可能避免从纳斯达克摘牌，并吸引更多投资者和分析师。 会议还将允许处理可能提请会议的其他事项。 只有截至2024年10月25日股东名册上的股东有权收到会议通知并参加会议。 公司强调了股东投票的重要性，并提供了通过互联网或邮寄进行投票的说明。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Syros Pharmaceuticals
    SYRS
    -- 0.1916
    2seventy bio
    TSVT
    -- 4.940
    Plus Therapeutics
    PSTV
    -- 1.6099
    Dogwood Therapeutics
    DWTX
    -- 10.545
    Anebulo Pharmaceuticals
    ANEB
    -- 1.380
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    美联储暂停降息，你如何调整持仓？
    美联储宣布基准利率维持在4.25%—4.50%不变，符合市场预期。你会如何配置资产？ 展开
    联邦公开市场委员会新闻发布会，2025年1月29日